Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Does Beta-lactam pharmacokinetic variability in critically ill patients justify therapeutic drug monitoring? A systematic review
Author: Sime, F.
Roberts, M.
Peake, S.
Lipman, J.
Roberts, J.
Citation: Annals of Intensive Care, 2012; 2(35):1-11
Publisher: SpringerOpen
Issue Date: 2012
ISSN: 2110-5820
Statement of
Fekade Bruck Sime, Michael S Roberts, Sandra L Peake, Jeffrey Lipman and Jason A Roberts
Abstract: The pharmacokinetics of beta-lactam antibiotics in intensive care patients may be profoundly altered due to the dynamic, unpredictable pathophysiological changes that occur in critical illness. For many drugs, significant increases in the volume of distribution and/or variability in drug clearance are common. When “standard” beta-lactam doses are used, such pharmacokinetic changes can result in subtherapeutic plasma concentrations, treatment failure, and the development of antibiotic resistance. Emerging data support the use of beta-lactam therapeutic drug monitoring (TDM) and individualized dosing to ensure the achievement of pharmacodynamic targets associated with rapid bacterial killing and optimal clinical outcomes. The purpose of this work was to describe the pharmacokinetic variability of beta-lactams in the critically ill and to discuss the potential utility of TDM to optimize antibiotic therapy through a structured literature review of all relevant publications between 1946 and October 2011. Only a few studies have reported the utility of TDM as a tool to improve beta-lactam dosing in critically ill patients. Moreover, there is little agreement between studies on the pharmacodynamic targets required to optimize antibiotic therapy. The impact of TDM on important clinical outcomes also remains to be established. Whereas TDM may be theoretically rational, clinical studies to assess utility in the clinical setting are urgently required.
Keywords: Pharmacokinetics; Pharmacodynamics; Beta-lactam; Antibiotics; Therapeutic drug monitoring; Critically ill
Rights: © 2012 Sime et al.; licensee Springer.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
RMID: 0020127299
DOI: 10.1186/2110-5820-2-35
Appears in Collections:Anaesthesia and Intensive Care publications

Files in This Item:
File Description SizeFormat 
hdl_79821.pdfPublished version354.51 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.